Published by Josh White on 2nd August 2021
(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma announced additional, "strong" data from its recent phase 2b clinical trial on Monday.
URL: http://www.digitallook.com/dl/news/story/32027507/...